Ursodeoxycholic acid CAS NO.128-13-2

Discover the therapeutic wonders of Ursodeoxycholic Acid(CAS No.128-13-2) (UDCA), a remarkable medication known for its efficacy in promoting liver health and managing various hepatobiliary conditions. Sourced from natural bile acids, this potent compound has been extensively studied and trusted by healthcare professionals worldwide. Embrace the power of Ursodeoxycholic Acid to support liver function and improve overall well-being.

What is Ursodeoxycholic Acid

Ursodeoxycholic Acid, also known as UDCA or ursodiol, is a secondary bile acid found in small quantities in human bile. However, in medicinal formulations, UDCA is derived from synthetic or bear bile sources. It is renowned for its unique properties that aid in reducing cholesterol levels in bile, protecting liver cells, and assisting in the dissolution of certain gallstones.

How Does Ursodeoxycholic Acid Work

UDCA's mechanism of action revolves around its dual benefits for liver health. Firstly, it helps to promote the flow of bile, reducing cholesterol saturation in the gallbladder, and preventing the formation of cholesterol-based gallstones. Secondly, UDCA exhibits cytoprotective properties, which means it safeguards liver cells from damage, inflammation, and apoptosis, thus supporting overall liver function.

Key Features and Benefits:

Gallstone Management: Ursodeoxycholic Acid is effective in dissolving small cholesterol gallstones, reducing the need for surgical interventions and facilitating a safer, non-invasive approach to gallstone management.

Primary Biliary Cholangitis (PBC): UDCA is the primary treatment for PBC, an autoimmune liver disease. It helps slow disease progression, improve liver function, and enhance patients' quality of life.

Non-alcoholic Fatty Liver Disease (NAFLD): UDCA shows promise in NAFLD treatment, assisting in reducing liver fat content and inflammation, potentially preventing disease progression.

Liver Protection: The cytoprotective properties of Ursodeoxycholic Acid make it an essential component in liver protection and regeneration strategies.

Cholesterol Reduction: UDCA can effectively lower serum cholesterol levels, making it beneficial for individuals with certain cholesterol-related conditions.

Arshine Pharmaceutical Co., Limited, located in Changsha, China, is affiliated with Arshine Group.

Originated in Shenzhen, China in 2007, with a number of wholly-owned subsidiaries, Arshine Group has established branches in Beijing, Shanghai, Shenzhen and Hangzhou, as well as a number of overseas offices.

With a global perspective and an average annual growth rate of over 30%, Arshine Group has become a leading professional health industry chain service group. Arshine Pharma, together with subsidiaries of Arshine Group, has expanded its business to 100 countries and regions in Asia, Europe, the Middle East and Africa.

Arshine Pharma is dedicated to providing one-stop procurement services for human APIs to global pharmaceutical companies. With years of experience in sourcing, Arshine Pharma has established strong relationships with a number of manufacturers and selected quality APIs from over 1000 suppliers worldwide. Our main products include antibiotics, antivirals, antifungals, steroids, antipyretics and analgesics, cardiovascular, digestive aids, vitamins and pharmaceutical excipients such as Citicolin sodium and Ursodeoxycholic Acid. For helping our customers enter the market smoothly, we also provide product registration and various types of documentation support.

At present, we have warehouses in Shanghai, Qingdao and Tianjin. We cooperate with more than 30 shipping companies in China to ensure fast delivery. Our company will contribute to developing the world's leading pharmaceutical raw material export service platform. Arshine Pharma has successfully provided human API supply solutions to more than 1,000 partners worldwide, helping human beings to overcome various diseases and have a healthy life.